Pfizer Has a New Sales Strategy–Will Be Selling Lipitor at Generic Prices When Patent Runs Out
Well this stands to certainly keep more patients taking “name” brand Lipitor and on the other hand throws a monkey wrench into the generic drug companies as far as their sales increasing. This will be interesting to see how this falls out at the retail 
drugs stores. This is a change that we haven’t seen before and maybe other drug companies could follow suit. Pharmacies make more money from generic drugs than they do name brand so will that pricing be changed too one might ask. BD
At least for consumers is may be one less formulary change to deal with.
You may be interested
Why Universal Healthcare is the Key to a Healthier and More Productive Society
Helen Heather - August 23, 2017The United States remains the only country in the world without a universal healthcare system. Many critics have stated that…
Care On The Road: How Telemedicine Can Reach Truck Drivers
Larry Alton - August 21, 2017Telemedicine is considered a powerful tool for individuals living in rural areas, far from adequate services or in need of…
Where Is The Balance? Pushing Back Against Consumer Health Tech
Larry Alton - August 18, 2017When Republican Congressman Jason Chaffetz glibly remarked that Americans struggling to afford insurance should choose between that and their smartphones,…
Featured Post
